About Rare Mutations and Fusions in Lung Cancer
Currently, there are 12 DNA-based alterations, or biomarkers, for which we have targeted therapies in NSCLC. Rare mutations and fusions include BRAF V600E, MET, NTRK, RET and ROS1.
New & Upcoming Events for Rare Mutations
Latest Updates in Rare Mutations
-
Podcast: What Do I Need to Know About Nutrition During Cancer Treatment?
Should you avoid sugar when you are living with lung cancer? Or should you eat anything you want? Are supplements something you need to consider? In this episode, non-small cell... -
Podcast: Managing the Emotional Rollercoaster of Lung Cancer
Living with lung cancer can take more than just a physical toll—it comes with a myriad of feelings, like anxiety, fear, and grief. In this episode, non-small cell lung cancer... -
Real Progress and Real Gaps: Highlights of the 2026 AACR Disparities Report
I have spent my career focused on the intersection between cancer research and public health. Since joining LUNGevity over a decade ago, it has been nothing short of a privilege to...
Sponsors
